Kaleido Biosciences is a clinical-stage healthcare company developing microbiome metabolic therapies or MMTs, which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes.
from RTT - Biotech https://ift.tt/2Ivtup3
via IFTTT
No comments:
Post a Comment